JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality (Q102058584)
Jump to navigation
Jump to search
scientific article published on 13 November 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality |
scientific article published on 13 November 2020 |
Statements
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality (English)
George Dranitsaris
Marco Falcone
Peter Richardson
Joanne X Shen
Giusy Tiseo
Lorenzo Ghiadoni
Agostino Virdis
Luis Romero Rizos
Almudena Avendaño-Céspedes
Laura Carrozzi
Pedro Manuel Sánchez-Jurado
Antonio Perrella
Laura Niccoli
Lourdes Sáez Méndez
Fabrizio Cantini
Stephen K Burley
Marta Mas Romero
Fernando Andrés Pretel
Rafaela Sánchez Simón-Talero
Andras G Miklosi
Francesco Menichetti
Ali Mirazimi
13 November 2020
1 reference
1 reference